Vish Medical Blog
Evidence-based insights from Dr. Arpana Pillay on weight loss, primary care, telehealth, and living well in Central Florida.
Some patients on semaglutide programs use lower doses than standard protocols to reduce side effects while maintaining weight loss benefits. Here is what the evidence and physician guidance say.
Fad diets promise quick results but rarely deliver lasting change. Here is why physician-supervised medical weight loss programs — including GLP-1 therapy — produce superior long-term outcomes.
Studies show significant weight regain occurs when GLP-1 medications are discontinued. Here is what patients and physicians should know about long-term weight maintenance after semaglutide.
Wondering how fast Ozempic works for weight loss? Here is a realistic month-by-month timeline showing what most patients experience during physician-supervised semaglutide therapy.
GLP-1 medications like semaglutide and tirzepatide are not right for everyone. Here are the 8 key questions your physician uses to determine whether you are a good candidate for treatment.
With branded GLP-1 medications expensive and sometimes unavailable, many patients turn to compounded semaglutide. Here is what the evidence and regulatory landscape say about safety and efficacy.
Nausea is the most common reason patients stop GLP-1 medications. With the right strategies, most side effects can be managed effectively. Here is a physician's guide to staying on track.
The first four weeks on semaglutide set the tone for your entire weight loss journey. Here is exactly what to eat, which foods to avoid, and what changes to expect in month one.
GLP-1 receptor agonists like semaglutide and tirzepatide have transformed obesity medicine — but how do they actually work? Here is the science explained in plain language.
Zepbound and Mounjaro both contain tirzepatide but are FDA-approved for different indications. Here is what patients considering tirzepatide for weight loss need to understand about these two brands.
Both Wegovy and Ozempic contain semaglutide, but they are approved for different purposes and come at different doses. Here is what patients need to know before starting GLP-1 therapy.
Semaglutide and tirzepatide are the two leading GLP-1 weight loss medications. Both produce significant results, but they work differently. Here is what the evidence says about choosing between them.
